Maze Therapeutics, Inc. Common Stock (MAZE) — Long-term Investment Intensity
Maze Therapeutics, Inc. Common Stock (MAZE) has a Long-term Investment Intensity of 15.8% as of June 2026. Long-term investments of $83.82 Million represent 15.8% of total assets of $531.62 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check MAZE cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Maze Therapeutics, Inc. Common Stock Long-term Investment Intensity (2025–2025)
This chart shows how Maze Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of June 2026, the intensity stands at 15.8%, reflecting long-term investments of $83.82 Million against total assets of $531.62 Million USD. For the complete balance sheet picture, see how large is Maze Therapeutics, Inc. Common Stock's balance sheet.
Annual Long-term Investment Intensity for Maze Therapeutics, Inc. Common Stock (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for Maze Therapeutics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Maze Therapeutics, Inc. Common Stock balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 4.6% | $18.11 Million | $397.13 Million | — |